iCoreConnect (NASDAQ:ICCT) Trading 2.9% Higher – Here’s What Happened

iCoreConnect Inc. (NASDAQ:ICCT)’s share price traded up 2.9% on Tuesday . The stock traded as high as $2.13 and last traded at $2.12. 17,636 shares traded hands during trading, a decline of 96% from the average session volume of 418,799 shares. The stock had previously closed at $2.06.

iCoreConnect Stock Up 2.9 %

The company’s 50 day moving average price is $2.63 and its two-hundred day moving average price is $5.61. The firm has a market cap of $2.59 million, a PE ratio of -0.03 and a beta of 0.87. The company has a current ratio of 0.11, a quick ratio of 0.11 and a debt-to-equity ratio of 7.93.

Insider Transactions at iCoreConnect

In other news, CEO Robert P. Mcdermott acquired 11,839 shares of the firm’s stock in a transaction dated Monday, November 25th. The shares were purchased at an average cost of $3.60 per share, for a total transaction of $42,620.40. Following the transaction, the chief executive officer now directly owns 61,494 shares of the company’s stock, valued at approximately $221,378.40. This trade represents a 23.84 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 59.42% of the company’s stock.

Institutional Trading of iCoreConnect

An institutional investor recently bought a new position in iCoreConnect stock. Magnus Financial Group LLC acquired a new stake in shares of iCoreConnect Inc. (NASDAQ:ICCT) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm acquired 25,010 shares of the company’s stock, valued at approximately $63,000. Magnus Financial Group LLC owned 2.05% of iCoreConnect at the end of the most recent reporting period. Hedge funds and other institutional investors own 13.42% of the company’s stock.

iCoreConnect Company Profile

iCoreConnect Inc, a cloud-based software and technology company, provides Health Insurance Portability and Accountability Act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States. The company’s products include iCoreRx, a HIPAA compliant electronic prescription software; iCorePDMP, a solution that checks the patient’s Prescription Drug Monitoring Program (PDMP) history before prescribing controlled substances; iCoreVerify and iCoreVerify+, a HIPAA compliant SaaS solution that automatically retrieves a patients insurance eligibility breakdown to verify their benefits in advance of their appointment and on-demand; iCoreHuddle and iCoreHuddle+, a tool to instantly reveal the revenue potential of each patient; and iCoreCodeGenius, a medical coding reference SaaS solution.